Vape Flavouring Vanillin Found to Disrupt Early Embryo Development

Vape Flavouring Vanillin Found to Disrupt Early Embryo Development

A new study out of the University of California, Riverside has found that vanillin, one of the most common flavouring chemicals used in e-cigarettes, can interfere with the earliest stages of human embryo development, at concentrations low enough to be reached through ordinary vaping.

What the Researchers Did

Vanillin turns up in more than half of tested e-liquids, and it’s used across nearly every type of vaping device on the market, from refillable pens to pod systems like JUUL to disposable products. Researchers Shabnam Etemadi and Prue Talbot wanted to know what happens when vanillin in vapes reaches an embryo during pregnancy, so they exposed human embryonic stem cells, a lab model that stands in for the earliest stage of a developing embryo, to the chemical at varying concentrations.

What they found was a chemical acting through a specific channel on the cell surface called TRPV4, which lets calcium flow into cells and plays a role in how tissue develops early on. Vanillin switched that channel on.

Two Different Kinds of Damage

The effect depended entirely on how much vanillin the cells were exposed to. At higher, micromolar concentrations, vanillin was straightforwardly toxic: cells died, colonies of stem cells stopped growing properly, detached, and their mitochondria, the structures that generate energy inside a cell, stopped functioning normally.

At much lower, nanomolar concentrations, thousands of times weaker, something different happened. Instead of killing the cells outright, vanillin pushed them to lose their pluripotency, meaning the cells started giving up their ability to become any type of tissue and instead began differentiating early into endoderm, one of the three foundational layers a developing embryo organises itself into. A marker called SOX17 that flags this shift lit up, while a marker for the undifferentiated, pluripotent state, OCT4, dropped off. Blocking the TRPV4 channel stopped both effects completely, confirming that channel was doing the work.

Why the Low Dose Matters More

It would be easy to assume the lower concentration is the less concerning one, but the researchers argue the opposite. The nanomolar levels that triggered this early differentiation aren’t some extreme lab scenario, they line up closely with what the researchers calculated would actually reach a pregnant vaper’s bloodstream during normal use. Using data on how much vanillin typical e-liquids contain and how efficiently it transfers from device to lungs to blood, the team modelled that someone taking just one to four puffs an hour on a moderately concentrated e-liquid would end up with blood levels close to the exact concentration that triggered the effect in their experiments.

That timing matters too. The stage of development the stem cells are modelling, roughly weeks two to three of pregnancy, is when the embryo is sorting itself into its three basic layers, a process called gastrulation. It’s also a stage when most women don’t yet know they’re pregnant.

What This Could Mean Outside the Lab

The study can’t say what vanillin in vapes does inside an actual pregnant body, only what it does to cells in a dish. But the researchers point out that this kind of very early disruption wouldn’t necessarily show up in the studies that track vaping and pregnancy outcomes, because those studies generally look at what happens at birth, low birthweight, premature delivery, and so on. An embryo that fails during gastrulation, before a pregnancy is even confirmed, would likely just look like a woman who didn’t conceive, or an early miscarriage with no clear cause. That’s the connection this research raises: a plausible biological reason why vaping has been associated with both difficulty conceiving and pregnancy loss in earlier studies, without those studies being able to explain why.

There’s also a regulatory gap sitting behind all of this. E-cigarette makers aren’t required to disclose which vaping flavouring chemicals are in their products or in what concentration, so a pregnant woman vaping a sweet, fruity or dessert-flavoured product, or even one labelled “tobacco” flavour, which frequently contains vanillin too, would have no way of knowing how much of the chemical she’s actually inhaling.

What the Researchers Are Recommending

The study’s authors are calling for two things: mandatory disclosure of flavouring ingredients on e-cigarette packaging, and for clinicians to start actively counselling patients who are pregnant or trying to conceive about the risks of vanillin in vapes. This isn’t the first flavour chemical this research group has flagged, they’ve previously found similar effects from menthol and a synthetic cooling agent called WS-23, both common vaping flavouring chemicals, both shown to disrupt these stem cells through a related family of channels.

Source: dbrecoveryresources

Leave a Reply

Your email address will not be published.